RMR vs. AMEH, ICFI, ASTH, MEG, HURN, HCKT, BWMN, III, JUNE, and LICN
Should you be buying The RMR Group stock or one of its competitors? The main competitors of The RMR Group include Apollo Medical (AMEH), ICF International (ICFI), Astrana Health (ASTH), Montrose Environmental Group (MEG), Huron Consulting Group (HURN), The Hackett Group (HCKT), Bowman Consulting Group (BWMN), Information Services Group (III), Junee (JUNE), and Lichen China (LICN). These companies are all part of the "management consulting services" industry.
The RMR Group (NASDAQ:RMR) and Apollo Medical (NASDAQ:AMEH) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.
42.3% of The RMR Group shares are held by institutional investors. Comparatively, 35.9% of Apollo Medical shares are held by institutional investors. 54.9% of The RMR Group shares are held by company insiders. Comparatively, 8.5% of Apollo Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
The RMR Group has a net margin of 4.59% compared to Apollo Medical's net margin of 3.56%. Apollo Medical's return on equity of 9.90% beat The RMR Group's return on equity.
The RMR Group has higher earnings, but lower revenue than Apollo Medical. The RMR Group is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.
The RMR Group has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Apollo Medical has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500.
In the previous week, The RMR Group and The RMR Group both had 3 articles in the media. Apollo Medical's average media sentiment score of 0.88 beat The RMR Group's score of -0.01 indicating that Apollo Medical is being referred to more favorably in the news media.
The RMR Group currently has a consensus target price of $32.00, indicating a potential upside of 36.00%. Apollo Medical has a consensus target price of $47.20, indicating a potential upside of 15.63%. Given The RMR Group's higher possible upside, equities analysts plainly believe The RMR Group is more favorable than Apollo Medical.
The RMR Group received 211 more outperform votes than Apollo Medical when rated by MarketBeat users. However, 60.79% of users gave Apollo Medical an outperform vote while only 60.38% of users gave The RMR Group an outperform vote.
Summary
Apollo Medical beats The RMR Group on 9 of the 17 factors compared between the two stocks.
Get The RMR Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for RMR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RMR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The RMR Group Competitors List
Related Companies and Tools
